City Fertility Centre Global

What City Fertility Centre Global does

City Fertility Centre Global is a privately held Australian IVF and fertility clinic network founded in 2003 and headquartered in Melbourne, operating 13 full-service fertility centres and 50+ consulting locations across New South Wales, Victoria, Queensland and Western Australia, with 7 day hospitals and a network of 60+ fertility specialists. The company provides the full spectrum of assisted reproductive technology (ART) services, from ovulation induction and IUI through to IVF, ICSI, frozen embryo transfer, preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), CAPA-IVM (for which its Sydney CBD clinic is the only TGA-licensed private site in Australia), MicroTESE surgical sperm retrieval, platelet-rich plasma therapy, and surrogacy pathways. Underlying technology includes the RI Witness RFID-based ART management system for sample tracking, time-lapse embryo monitoring deployed across all laboratories, and vitrification methods inherited from its partnership with CHA Medical Group; a Spermsearch AI capability is currently in trial for surgically retrieved sperm samples.

The group operates an integrated ecosystem of sub-brands addressing distinct patient and price tiers: Rainbow Fertility (LGBTQ+ focused), City IVF (bulk-billed ICSI), Addam Donor Bank and Eeve Donor Bank (Australia's largest donor sperm and egg banks respectively), Sperm Donors Australia, and City Fertility Perth. Revenue mechanics combine self-pay treatment cycles (IUI ~A$1,050, PRP A$300-A$450 add-on, full IVF priced by individual plan), Medicare rebates on eligible treatments, private health insurance contributions for hospital-related costs, and a newer employer-sponsored fertility wellness channel. Go-to-market is hybrid: direct-to-consumer via a national booking line, website and free fertility health checks, supported by a GP and specialist referral network, plus a flagship strategic partnership with CHA Medical Group (17 hospitals, 70,000+ annual IVF cycles) and Singapore Medical Group that provides access to global research, clinical IP, and international patient flows. The company is led by CEO Adnan Catakovic, CFO Liam Kim, COO Natalie Hayworth, CCO Cathy David and National Scientific Director Yanhe Liu, and reports 23,000+ babies born through its care and a 42.5% IVF success rate for patients under 40 (2024 national data).

Name

City Fertility Centre Global

Legal name

City Fertility

Website

https://cityfertility.com.au

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Reproductive Health Services

NAICS

Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Hospitals (8060)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA)

Keywords

• IVF treatment services
• Fertility preservation
• Donor programs
• Reproductive medicine
• Assisted reproductive technology

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Fertility Treatment Services: Core revenue from IVF, ICSI, IUI, FET, egg freezing, sperm freezing, donor programs, and other fertility treatments. Medicare rebates available for eligible treatments. Private health insurance contributions offset hospital-related costs.
2. IUI Treatment: Intrauterine insemination treatment at $1,050 with estimated $975 out-of-pocket after Medicare rebate. Covered by Medicare with typical success rates of 10% for partner sperm (under 39 years) and 21.4% for donor sperm (under 35 years).
3. PRP Add-on Treatment: Platelet-Rich Plasma therapy offered as add-on to IVF cycles at $300-$450 per treatment depending on location. Not covered by Medicare as adjuvant therapy.
4. Consultation Fees: Initial consultations and specialist appointments. Medicare rebates apply. International patients pay for consultations, IVF treatment cycles, and fertility preservation services.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

City Fertility Centre Global is a private Australian fertility clinic network providing a full spectrum of assisted reproductive technology services. Core offerings include in-vitro fertilisation (IVF), ICSI, frozen embryo transfer, ovulation induction, IUI, fertility preservation (egg and sperm freezing), donor programs, genetic testing, and surrogacy pathways. The company operates 13 full-service fertility centres with 7 day hospitals and over 50 consulting locations across Australia, supported by more than 60 fertility specialists.

Product overview

City Fertility is a comprehensive fertility care network offering a full spectrum of treatment options from basic ovulation induction to advanced reproductive technologies. The core offering includes IVF, ICSI, FET, and specialised treatments such as CAPA-IVM, PRP therapy, PGT, and MicroTESE. The organisation provides donor programs through Addam Donor Bank (sperm) and Eeve Donor Bank (eggs), with Rainbow Fertility serving the LGBTQ+ community. Patient engagement is supported through My Fertility Portal App, Addam Donor Bank App, and Eeve Donor Bank App. The integrated approach combines diagnostic testing, fertility preservation, treatment services, and support care to address diverse family-building needs.

Differentiator

Problem solved

Functional benefit

Brands

• Rainbow Fertility: Australia's first and only dedicated fertility and IVF service catering exclusively for the LGBTQ+ community.
• City IVF
• Addam Donor Bank
• Eeve Donor Bank
• Sperm Donors Australia
• City Fertility Perth

Products and services

• IVF (In Vitro Fertilisation) In-vitro fertilisation where eggs are collected, fertilised with sperm in a laboratory, and the resulting embryo is transferred to the uterus, offered to individuals and couples experiencing infertility.
• ICSI (Intracytoplasmic Sperm Injection) Specialised IVF technique where a single sperm is injected directly into a mature egg to assist fertilisation, primarily used for male factor infertility.
• FET (Frozen Embryo Transfer) Thawing and transfer of cryopreserved embryos from a previous IVF cycle into the uterus, avoiding the need for another full IVF cycle.
• CAPA-IVM (Capacitation-Prepared In Vitro Maturation) Enhanced IVM procedure using a two-step culture process that slows maturation for 24 hours before finalising it, yielding superior outcomes; available only at the Sydney CBD clinic under TGA licensing.
• IUI (Intrauterine Insemination) Direct insertion of washed and concentrated sperm into a woman's uterus around ovulation to improve chances of conception; priced at $1,050 with Medicare rebates available.
• OI (Ovulation Induction) Use of medication to regulate or stimulate ovulation for women with irregular cycles or conditions such as PCOS.
• PRP (Platelet-Rich Plasma) Therapy Concentration of patient's own platelets introduced into the uterus to improve endometrial thickness and receptivity for embryo implantation; priced at $300-$450 per treatment.
• PGT (Preimplantation Genetic Testing) Laboratory assessment of IVF-created embryos for chromosomal abnormalities (PGT-A), single gene defects (PGT-M), or structural rearrangements (PGT-SR) before transfer.
• MicroTESE (Microsurgical Sperm Extraction) Microsurgical testicular sperm extraction procedure to locate and retrieve sperm in men with severe male factor infertility or azoospermia.
• Egg Freezing Preservation of fertility through freezing of eggs for future use, using vitrification techniques with blastocyst thawing survival rates above 90%.
• Sperm Freezing Preservation of fertility through freezing of sperm for future use.
• Donor Sperm Program Access to donor sperm from Addam Donor Bank, Australia's largest donor sperm bank, for individuals and couples requiring donor sperm to achieve pregnancy.
• Donor Egg Program Access to donor eggs from Eeve Donor Bank, Australia's dedicated donor egg bank, for individuals and couples requiring donor eggs to achieve pregnancy.
• Donor Embryo Program Access to donated embryos for individuals and couples requiring donor embryos to achieve pregnancy.
• Surrogacy Fertility treatment pathway where a surrogate carries and gives birth to a baby for intended parent(s).
• Fertility Health Check Free fertility health check with GPs providing guidance on fertility status and next steps, used as a top-of-funnel patient acquisition entry point.
• Female Fertility Testing Comprehensive fertility testing services for female patients including ovarian reserve assessment.
• Male Fertility Testing Semen analysis and male fertility testing services, often a starting point for male factor infertility diagnosis.
• Genetic Carrier Screening Genetic screening to identify carriers of inherited genetic conditions.
• Support Care Services Infertility counselling, dietitian services, complementary therapies, and adjuvant therapies to support patients through fertility treatment.
• Rainbow Fertility (LGBTQ+ Fertility Service) Subsidiary dedicated fertility and IVF service for the LGBTQ+ community, offering donor and surrogacy pathways.
• Addam Donor Bank Australia's largest donor sperm bank offering a diverse range of donors for fertility treatment.
• Eeve Donor Bank Australia's dedicated donor egg bank helping people achieve parenthood through donor eggs.
• My Fertility Portal App Patient portal application for managing fertility treatment journeys and accessing information and resources.
• Addam Donor Bank App Mobile application for accessing Addam donor sperm bank services and donor selection.
• Eeve Donor Bank App Mobile application for accessing Eeve donor egg bank services and donor selection.

Quantifiable outcome

• 23,000+ babies born through City Fertility care
• +4 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Twelve partnerships are on record, tiered flagship, core and minor.

• CHA Medical GroupflagshipStrategic or Co-development PartnerPartnership with CHA Medical Group, a leading healthcare operator and premier global leader in fertility and women's health. CHA operates 70,000+ IVF cases annually across 17 hospitals globally with 94+ medical institutions. Provides City Fertility with access to world-class expertise, research, and innovation. CHA's Gangnam and Seoul Station Fertility Centers are among the largest and most advanced IVF facilities in Asia.
• Singapore Medical Group (SMG)coreStrategic or Co-development PartnerPartnership with Singapore Medical Group (SMG), one of Southeast Asia's largest multi-disciplinary specialist clinic groups. SMG is part of the CHA Medical Group partnership providing expanded regional network and expertise.
• Addam Donor BankcoreStrategic or Co-development PartnerExclusive access to Australia's largest donor sperm bank. Addam offers diverse range of sperm donors for patient treatment.
• Eeve Donor BankcoreStrategic or Co-development PartnerExclusive access to Australia's largest donor egg bank. Eeve offers diverse range of egg donors for patient treatment.
• University of New South Wales (UNSW)coreStrategic or Co-development PartnerResearch partnership with UNSW including collaboration on CAPA-IVM treatment with Professor Robert Gilchrist and Professor William Ledger.
• University of MelbournecoreStrategic or Co-development PartnerAcademic research collaboration in reproductive medicine and fertility treatment development.
• Monash UniversitycoreStrategic or Co-development PartnerAcademic research collaboration in reproductive medicine and fertility science.
• University of Western AustraliacoreStrategic or Co-development PartnerAcademic research collaboration in reproductive medicine and fertility research.
• National University of SingaporecoreStrategic or Co-development PartnerInternational research collaboration in reproductive medicine and fertility science.
• KK Women's and Children's Hospital SingaporecoreStrategic or Co-development PartnerInternational clinical collaboration in women's health and fertility treatment.
• Rabbitohs (NRL)minorGTM or Marketing PartnerMen's Fertility Matters partnership with Rabbitohs NRL team to promote male fertility awareness and services to sports fans and broader community.
• Rainbow FertilitycoreOthersSubsidiary brand - Australia's first and only dedicated fertility and IVF service catering exclusively for LGBTQ+ community.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Inception Fertility: US-based largest provider of fertility services operating clinics such as Prelude and Pathways. Comparable multi-clinic private IVF network with similar technology investments and patient acquisition model.
• Genea: Major Australian private fertility group known for proprietary embryology technology (Genea Biomedx) and clinics in NSW, VIC, and ACT. Competes with City Fertility on advanced treatments, success rates, and specialist networks.
• CARE Fertility: UK-based private IVF network offering full-service fertility treatments including IVF, ICSI, PGT, and donor programs. Comparable international private operator competing on technology, success rates, and integrated patient experience.
• Virtus Health: Australia's largest IVF network operating brands such as IVFAustralia, Melbourne IVF, and Queensland Fertility Group. Direct head-to-head competitor to City Fertility across NSW, VIC, QLD, and WA with similar service mix and comparable technology stack.
• Monash IVF Group: ASX-listed Australian IVF operator with national clinic footprint and full-service fertility offering. Direct competitor with overlapping treatments (IVF, ICSI, PGT, donor programs) and comparable success-rate emphasis.

Regional players

• Flinders Fertility: South Australia-based IVF provider offering full-service fertility treatments. Geographic non-overlap but directly comparable in service menu and clinic-based delivery model.
• Repromed: Adelaide and regional IVF operator providing IVF, ICSI, and donor programs. Comparable service offerings to City Fertility but focused on South Australia and regional Australia.
• Singapore Medical Group: Southeast Asian multi-disciplinary specialist clinic group and CHA Medical Group partner. Operates fertility and women's health services in Singapore; overlaps with City Fertility's international patient pipeline and technology partnership.
• TasIVF: Tasmania-based fertility clinic offering full IVF services and donor programs. Operates in a different geography but mirrors City Fertility's clinic-based treatment model.

Others

• CHA Medical Group: Korea-headquartered global IVF and women's health operator running 70,000+ IVF cycles annually across 17+ hospitals. Strategic partner of City Fertility providing expertise, research collaboration, and inbound international patient flow rather than direct Australian clinic competition.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/cityfertility
• Facebookfacebook.com/264274286948444
• LinkedInlinkedin.com/company/city-fertility-centre

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about City Fertility Centre Global